During this August, FDA 483s month here at FDAzilla, we repost some of our favorite pieces related to 483s. Here’s another from the QA Pharm.
During this August, FDA 483s month here at FDAzilla, we repost some of our favorite pieces related to 483s. Here’s one from the QA Pharm.
The high layoff numbers in the pharmaceutical industry and poor job prospects in a weak economy have flooded the market with would-be consultants to pharma
My blood boils when I read an article such as the one that appeared in the New York Times yesterday entitled Supply of a Cancer Drug
Like anyone else, coming to the end of the year brings a time of reflection and anticipation. I look back and ask the question, “Have
Most GMP training that I encounter is not necessarily bad–just irrelevant. In fact the same could be said for the Training Department in general. They